NFocus Neuromedical
NFocus Neuromedical
NFocus Neuromedical
Investors in Nfocus
About Us
Nfocus is a privately held venture capital-backed company. Major investments have been made by Oxford Bioscience Partners, Technology Partners, e-Planet Ventures and In-Cube Ventures.
    Oxford Bioscience: Oxford Bioscience Partners (www.oxbio.com), established in 1992, is a venture capital firm that provides equity financing and management assistance to emerging, entrepreneurial-driven companies within the life sciences and healthcare sectors. With approximately $1B of committed capital under management, OBP has invested in over 140 life science companies worldwide, and has successfully leveraged the extensive research, operating, and financial expertise and experience of its team of investment professionals.

    Technology Partners: Founded over 20 years ago as a private venture capital firm, Technology Partners (www.technologypartners.com) manages a total of more than $400 million of investment capital. Investments are being made currently from Technology Partners VII, L.P., a $250 million fund. Tech Partners serve principally as a lead investor and business advisor to both Life Science and Cleantech companies.

    ePlanet Ventures: ePlanet Ventures (www.eplanetventures.com) seeks to provide superior returns to its investors by making private equity investments on a global basis in companies where the application of innovation in technology and/or business models has the potential to create high-growth, category- dominant companies. Founded in 1999, ePlanet Ventures pioneered the development of a true global venture capital business model and was the first venture capital firm that utilized a global model with offices in Asia, Europe and the United States.

    InCube Ventures: InCube Ventures (www.incubevc.com) is a venture capital firm focused on innovative medical technologies that can significantly improve clinical outcomes. ICV is led by Managing Director Mir Imran, one of the world's most successful medical device entrepreneurs and investors.